# Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)

> **NCT02211664** · PHASE4 · COMPLETED · sponsor: **Flanders Medical Research Program** · enrollment: 120 (actual)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DEVICE:** Passeo-18 balloon
- **DEVICE:** Passeo-18 Lux drug releasing balloon
- **DEVICE:** Pulsar-18 stent

## Key facts

- **NCT ID:** NCT02211664
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2017-02
- **Final completion:** 2018-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211664, "Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02211664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*